US FDA clears J&J Covid-19 vaccine doses after months-long delay
After a thorough review of a troubled Emergent manufacturing facility, US regulators authorised two batches of the vaccine’s underlying drug substance made at the site
11 June 2021 - 19:57
The US Food and Drug Administration (FDA) released 10-million doses of the Johnson & Johnson (J&J) Covid-19 vaccine produced by Emergent BioSolutions, according to people familiar with the matter.
After a thorough review of a troubled Emergent manufacturing facility, US regulators authorised two batches of the vaccine’s underlying drug substance made at the site, the FDA said in a statement on Friday, without disclosing how many doses would be released...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.